No, generally taking GLP-1 medications such as Mounjaro, Ozempic, or Wegovy is not a permanent disqualifier for plasma donation
Research suggests that combining weight-management medication with regular exercise may support healthier maintenance of weight and body composition over time compared with either strategy alone
Other GLP-1 receptor agonists, different medications, and non-drug treatments can all play a role in managing diabetes and supporting weight loss
GLP-1 microdosing means taking a dose of a GLP-1 medicine, like Ozempic (semaglutide) or Mounjaro (tirzepatide), thats smaller than the dose prescribed by your doctor
The relevant question is whether a defined product has shown meaningful benefit for a particular patient group with acceptable risks and appropriate monitoring
NHS and NICE-recommended weight management approaches including structured lifestyle interventions, behavioural support, and where appropriate, licensed pharmacological treatments such as orlistat or GLP-1 receptor agonists have a substantially stronger evidence base than L-carnitine supplements